Tag: eryaspase
ERYTECH announces the publication of positive results from the phase 2 trial evaluating eryaspase in hypersensitive ALL in the British Journal of Haematology – 04/06/2022 at 22:05
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected] Lyon (France), and Cambridge, MA…
ERYTECH announces the presentation of the results of two clinical studies evaluating eryaspase in the treatment of pancreatic cancer at the ASCO-GI symposium – 01/24/2022 at 07:30
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected] – Presentation, in the form…